This guideline addresses the evaluation of male infertility, which can arise from a wide array of conditions, and discusses issues that may affect infertility treatment or the health of the patient and offspring.

In about half of couples with infertility, a problem with male infertility affects the couple’s ability to conceive a pregnancy. To be fertile, men must have enough sperm in their semen, and these sperm must be healthy. Sperm production is driven by hormones.

Mar 5, 2025 · Our trial showed that treating male partners with a week of oral metronidazole and topical clindamycin, together with treatment of women, resulted in a lower rate of recurrence of bacterial ...

Nov 22, 2022 · This article summarizes guidelines on identifying and addressing infertility in men from the American Urological Association and American Society for Reproductive Medicine.

Jan 7, 2020 · Importance: Dietary supplements marketed for male fertility commonly contain folic acid and zinc based on limited prior evidence for improving semen quality. However, no large-scale trial has examined the efficacy of this therapy for improving semen quality or live birth.

Feb 2, 2022 · We found that 0.5 mg/d of dutasteride, which is used off-label for male AGA in North America, is more efficacious than 1 mg/d of finasteride (which is approved by the US Food and Drug Administration [FDA] for male AGA).

Male infertility is emerging as an important cause of infertility worldwide; the growing scientific interest in this field of reproductive medicine is demonstrated by the increasing number of scientific papers published by journals dedicated to andrology, urology, and …

JAMA. 2018 Apr 3;319 (13):1375-1376. doi: 10.1001/jama.2018.3182.Evaluation and Treatment of Male Hypogonadism

Jama, worn by the Nawab of Carnatic and his son. Maratha ruler Rajaram I wearing a Jama. The term jama (Hindustani: जामा, جام ; Bengali: জামা; Odia: ଜାମା ) refers to a long coat which was popular in South Asia during the early modern era.

Jul 25, 2024 · This narrative review describes the identification of male BRCA1/2 pathogenic variant carriers, associated cancer risks, and management recommendations.